Home ›
Entities
› academia
› Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686
Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686
Research article (Neuro-Oncology, 2018) · cited 35× · AI/ML
Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686
Summary
Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686 is a scholarly article[1].
Key Facts
Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686. Retrieved May 24, 2026, from https://4ort.xyz/entity/prognostic-value-of-contrast-enhancement-and-flair-for-survival-in-newly-diagnosed-glioblastoma-treated-with-and-without
MLA“Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/prognostic-value-of-contrast-enhancement-and-flair-for-survival-in-newly-diagnosed-glioblastoma-treated-with-and-without.
BibTeX@misc{4ortxyz_prognostic-value-of-contrast-enhancement-and-flair-for-survival-in-newly-diagnosed-glioblastoma-treated-with-and-without_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686}}, year = {2026}, url = {https://4ort.xyz/entity/prognostic-value-of-contrast-enhancement-and-flair-for-survival-in-newly-diagnosed-glioblastoma-treated-with-and-without}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686 — https://4ort.xyz/entity/prognostic-value-of-contrast-enhancement-and-flair-for-survival-in-newly-diagnosed-glioblastoma-treated-with-and-without (retrieved 2026-05-24)
